Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the multicenter automatic defibrillator implantation trial-reduce inappropriate therapy (MADIT-RIT) trial

Circulation

Volumn 128, Issue 7, 2013, Pages 694-701

  Ruwald, Martin H ^a,b   Zareba, Wojciech ^a   Jons, Christian ^b   Zhang, Claire ^a   Ruwald, Anne Christine H ^a,b   Olshansky, Brian ^c   McNitt, Scott ^e   Thomsen, Poul Erik Bloch ^d   Shoda, Morio ^a   Merkely, Bela ^f   Moss, Arthur J ^a   Kutyifa, Valentina ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF IOWA HEALTH CARE   (United States)

^d AALBORG UNIVERSITY   (Denmark)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Defibrillators; Diabetes mellitus; Heart failure; Implantable; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTING HEART RATE; RISK ASSESSMENT;

DEFIBRILLATORS, IMPLANTABLE; DIABETES MELLITUS; HEART FAILURE; MORTALITY;

AGED; ALGORITHMS; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; DIABETES COMPLICATIONS; ELECTRIC COUNTERSHOCK; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; PROPORTIONAL HAZARDS MODELS; RISK; SINGLE-BLIND METHOD; TACHYCARDIA, VENTRICULAR; UNNECESSARY PROCEDURES;

EID: 84882241755     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.002472     Document Type: Article

References (39)

1. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275-2283.
2. George J, Barsheshet A, Moss AJ, Martin D, Ouellet G, McNitt S, Goldenberg I. Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy. Ann Noninvasive Electrocardiol. 2012;17:14-21.
3. Wittenberg SM, Cook JR, Hall WJ, McNitt S, Zareba W, Moss AJ; Multicenter Automatic Defibrillator Implantation Trial. Comparison of efficacy of implanted cardioverter-defibrillator in patients with versus without diabetes mellitus. Am J Cardiol. 2005;96:417-419.
4. Martin DT, McNitt S, Nesto RW, Rutter MK, Moss AJ. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT). Circ Heart Fail. 2011;4:332-338.
5. Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H, McNitt S, Polonsky S, Andrews M, Dwyer EM, Hall WJ, Moss AJ; MADIT II Investigators. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm. 2009;6: 468-473.
6. Bergner DW, Goldberger JJ. Diabetes mellitus and sudden cardiac death: What are the data? Cardiol J. 2010;17:117-129.
7. Sandesara CM, Sullivan RM, Russo AM, Li W, Kendig A, Day JD, Mullin C, Stolen K, Olshansky B. Older persons with diabetes receive fewer inappropriate ICD shocks: Results from the INTRINSIC RV trial. J Cardiovasc Transl Res. 2011;4:27-34.
8. Schuger C, Daubert JP, Brown MW, Cannom D, Estes NA 3rd, Hall WJ, Kayser T, Klein H, Olshansky B, Power KA, Wilber D, Zareba W, Moss AJ. Multicenter Automatic Defibrillator Implantation Trial: Reduce Inappropriate Therapy (MADIT-RIT): Background, rationale, and clinical protocol. Ann Noninvasive Electrocardiol. 2012;17:176-185.
9. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML; MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol. 2004;43:1459-1465.
10. Cox DR. Regression models and life-tables. J Royal Stat Soc B. 1972;34:187-220.
11. Ahmed I, Nelson WB, House CM, Zhu DW. Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. Heart Int. 2010;5:e4.
12. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006;114:2766-2772.
13. Desai H, Aronow WS, Ahn C, Gandhi K, Hussain S, Lai HM, Sharma M, Frishman WH, Cohen M, Sorbera C. Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure. Am J Cardiol. 2010;105:1336-1338.
14. Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ; MADIT-II Investigators. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: Findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol. 2005;46:1712-1720.
15. Whang W, Albert CM, Sears SF Jr, Lampert R, Conti JB, Wang PJ, Singh JP, Ruskin JN, Muller JE, Mittleman MA; TOVA Study Investigators. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: Results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol. 2005;45:1090-1095.
16. Elhendy A, Chapman S, Porter TR, Windle J. Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death. J Am Coll Cardiol. 2005;46:1721-1726.
17. Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, Higenbottam J, Khaykin Y. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2010;33:320-329.
18. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011;57:556-562.
19. Gold MR, Linde C, Abraham WT, Gardiwal A, Daubert JC. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm. 2011;8:679-684.
20. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
21. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
22. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 2008;121:748-757.
23. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-397.
24. Schelbert HR. Coronary circulatory function abnormalities in insulin resistance: Insights from positron emission tomography. J Am Coll Cardiol. 2009;53(suppl):S3-S8.
25. Schindler TH, Facta AD, Prior JO, Cadenas J, Zhang XL, Li Y, Sayre J, Goldin J, Schelbert HR. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus. Eur J Nucl Med Mol Imaging. 2009;36:219-229.
26. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
27. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators. Cardiacresynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-1338.
28. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017.
29. Bhavnani SP, Kluger J, Coleman CI, White CM, Guertin D, Shafi NA, Yarlagadda RK, Clyne CA. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm. 2010;7: 755-760.
30. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-1365.
31. Kreuz J, Horlbeck F, Linhart M, Mellert F, Fimmers R, Schrickel J, Nickenig G, Schwab JO. Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy. Europace. 2012;14:1596-1601.
32. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE Survival Study. Circulation. 2010;122:2359-2367.
33. Bhavnani SP, Coleman CI, White CM, Clyne CA, Yarlagadda R, Guertin D, Kluger J. Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy. Europace. 2008;10:854-859.
34. Yang JH, Byeon K, Yim HR, Park JW, Park SJ, Huh J, Kim JS, On YK. Predictors and clinical impact of inappropriate implantable cardioverter- defibrillator shocks in Korean patients. J Korean Med Sci. 2012;27:619-624.
35. Bang CN, Greve AM, Abdulla J, Kober L, Gislason GH, Wachtell K. The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: A systematic review and meta-analysis. Int J Cardiol. September 19, 2012. doi:10.1016/j. ijcard.2012.08.056. http://www.internationaljournalofcardiology. com/article/S0167-5273%2812%2901085-6/abstract. Accessed January 25, 2013.
36. Aronow WS, Frishman WH. Management of hypercholesterolemia in older persons for the prevention of cardiovascular disease. Cardiol Rev. 2010;18:132-140.
37. Meyer C, Milat F, McGrath BP, Cameron J, Kotsopoulos D, Teede HJ. Vascular dysfunction and autonomic neuropathy in type 2 diabetes. Diabet Med. 2004;21:746-751.
38. Kudat H, Akkaya V, Sozen AB, Salman S, Demirel S, Ozcan M, Atilgan D, Yilmaz MT, Guven O. Heart rate variability in diabetes patients. J Int Med Res. 2006;34:291-296.
39. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, Heiss G; Atherosclerosis Risk in Communities (ARIC) Study. Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2005;28:668-674.